Inventor

KHANNA ISH K

US51 patents

⚠️ This page may combine multiple inventors who share the name “KHANNA ISH K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KHANNA ISH K

SEARLE & CO

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides

Prodrugs of benzenesulfonamide-containing COX-2 inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Substituted pyrrolyl compounds for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation

2- and 3- amino and azido derivatives of 1,5-iminosugars

2- and 3- amino and azido derivatives of 1,5-iminosugars

5-substituted-4-phenyl-5H-imidazo[4,5-c]pyridine derivatives

Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines

Heterocyclo-substituted imidazoles for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

5-substituted [4,5-c] imidazopyridines and pharmaceutical use thereof

5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity

5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity

Heterocyclic glycyl β-alanine derivatives

Substituted pyrazolyl benzenesulfonamides for the treatment of asthma

B preparation of 2- and 3- azido derivates of 1,5-iminosugars

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors

2- and 3- amino azido derivatives of 1,5-iminosugars

2-substituted tertiary carbinol derivatives of deoxynojirimycin

Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation

Substituted-phenyl (N,N&#39;-cycloalkyl/alkyl carboxamide)-1H/3H-imidazo[4,5-b]pyridine compounds as PAF antagonists

Intermediates for 2,3-diamino-1,5-iminosugars

Intermediates for 3-amino and 3-azido derivatives of 1,5-iminosugars

2-substituted tertiary carbinol derivative of 1,5-iminosugars

Intermediates for 2-amino and azido derivatives of 1,5-iminosugars

N,N&#39;-cycloalkyl/alkyl carboxamide 4H-imidazo-[4,5-b]pyridine compounds as PAF antagonists

2-substituted tertiary carbinol derivatives of 1,5-iminosugars

2-substituted tertiary carbinol derivatives of 1, 5-iminosugars

2-substituted tertiary carbinol derivatives of 1,5-iminosugars

2-substituted tertiary carbinol derivatives of 1,5-iminosugars

2-substituted tertiary carbinol derivatives of 1,5-iminosugars

PHARMACIA CORP

Substituted pyrazoles as p38 kinase inhibitors

Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors

Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Substituted pyrazoles as p38 kinase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors

(unassigned)

Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions

KHANNA ISH K

Heterocyclo-substituted imidazoles for the treatment of inflammation

Substituted-phenyl (N,N'-cycloalkyl/alkyl carboxamide)-1H/3H-imidazo[4,5-b]pyridine compounds as PAF antagonists

N,N'-cycloalkyl/alkyl carboxamide 4H-imidazo-[4,5-b]pyridine compounds as PAF antagonists